Practice guidelines for diseases caused by Aspergillus

Medicine and Dentistry

• Aspergillus 100%
• Aspergilloma 100%
• Diseases 100%
• Corticosteroid 100%
• Hemoptysis 80%
• Itraconazole 80%
• Oral 80%
• Amphotericin 60%
• Morbidity 40%
• Invasive Aspergillosis 40%
• Immunocompromised Patient 40%
• Allergic Bronchopulmonary Aspergillosis 40%
• Disease Predisposition 20%
• Thorax Radiography 20%
• Adjuvant Therapy 20%
• Aspergillosis 20%
• Silo-Filler's Disease 20%
• Lipid 20%
• Intravenous Drug Administration 20%
• Kidney Function 20%
• Treatment Duration 20%
• Personal Experience 20%
• Creatinine 20%
• Infection 20%
• Spirometry 20%
• Health Care Cost 20%
• Amphotericin B Deoxycholate 20%
• Disease Course 20%
• Organ Systems 20%
• Deoxycholic Acid 20%
• Sarcoidosis 20%
• Combination Chemotherapy 20%
• Corticosteroid Therapy 20%
• Lung Function 20%
• Immunotherapy 20%
• Prednisone 20%
• Immunoglobulin E 20%
• Clinical Symptom 20%
• Nephrotoxicity 20%
• Bronchial Artery Embolization 20%

Pharmacology, Toxicology and Pharmaceutical Science

• Aspergillus 100%
• Diseases 100%
• Corticosteroid 100%
• Aspergilloma 83%
• Itraconazole 66%
• Hemoptysis 66%
• Amphotericin 50%
• Morbidity 33%
• Immunocompromised Patient 33%
• Invasive Aspergillosis 33%
• Allergic Bronchopulmonary Aspergillosis 33%
• Intravenous Therapy 16%
• Nephrotoxicity 16%
• Disease Predisposition 16%
• Lipid 16%
• Infection 16%
• Disease Course 16%
• Chemotherapy Regimens 16%
• Creatinine 16%
• Lung Disease 16%
• Immunotherapy 16%
• Prednisone 16%
• Aspergillosis 16%
• Maximum Tolerated Dose 16%
• Immunoglobulin E 16%
• Sarcoidosis 16%
• Amphotericin B Deoxycholate 16%
• Deoxycholic Acid 16%